Elevated INR in a COVID‐19 patient after concomitant administration of favipiravir and warfarin: A case report-Reference-Cited by-同舟云学术

Elevated INR in a COVID‐19 patient after concomitant administration of favipiravir and warfarin: A case report

Published:2021-08-02 Issue: Volume: Page:
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Sekimoto Masao¹^ORCID,Imai Toru²,Hidaka Shinji³^ORCID,Chiba Nobutaka⁴,Sakurai Atsushi⁴,Hata Mitsumasa⁵,Kikuchi Norikazu¹

Affiliation:

1. Department of Pharmacy Nihon University Hospital Tokyo Japan

2. Department of Pharmacy Nihon University Itabashi Hospital Tokyo Japan

3. Department of Pharmaceutical Regulatory Science School of Pharmacy Nihon University Chiba Japan

4. Division of Emergency and Critical Care Medicine Department of Acute Medicine Nihon University School of Medicine Tokyo Japan

5. Department of Cardiovascular Surgery Nihon University Hospital Tokyo Japan

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13499

Reference20 articles.

1. Favipiravir: A new and emerging antiviral option in COVID-19

2. RETRACTED ARTICLE: Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study

3. Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial

4. Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019‐nCoV Infection

5. Fujifilm (Corporation).Toyama Chemical Co. Ltd. (Fujifilm).The Drug Interview Form of Favipiravir (Avigan®).http://fftc.fujifilm.co.jp/med/abigan/pack/pdf/abigan_if_01.pdf. Accessed March 27 2021 (in Japanese); 2019 (April. 2019 version).

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Synergism of Anticancer Action in Combination with Favipiravir and Paclitaxel on Neuroblastoma Cells;Medicina;2023-12-30

2. Drug Interaction Between Favipiravir and Warfarin: A Case Series;Hospital Pharmacy;2023-12-29

3. Pharmacogenetic Markers of Favipiravir Safety in COVID-19 Treatment;Antibiotics and Chemotherapy;2023-10-23

4. Elevated INR in a COVID-19 patient after concomitant administration of azvudine and anticoagulants;Frontiers in Pharmacology;2023-05-19

5. Potential Drug Interaction Between Favipiravir and Warfarin in Patients With COVID‐19: A Real‐World Observational Study;The Journal of Clinical Pharmacology;2022-10-17